The American Journal of Medicine
Volume 118, Issue 12 , Pages 1413.e15-1413.e22 , December 2005

Hepatitis B virus infection: Current status

  • Ponsiano Ocama, MD

      Affiliations

    • Mulago Hospital, Kampala, Uganda
  • ,
  • Christopher K. Opio, MD

      Affiliations

    • Mulago Hospital, Kampala, Uganda
  • ,
  • William M. Lee, MD

      Affiliations

    • University of Texas Southwestern Medical School, Division of Digestive and Liver Diseases, Dallas, Tex
    • William M. Lee, MD, receives research support from Schering, Roche, Bristol Myers Squibb, Gilead, and Glaxo SmithKline.
    • Corresponding Author InformationRequests for reprints should be addressed to William M. Lee, MD, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75390-9151

Received 24 May 2005 ,Revised 15 June 2005 ,Accepted 15 June 2005.

  • Image Result

    Overwhelming hepatitis B infection with immunosuppression. Photomicrographs providing evidence that immunosuppression leads to overwhelming infection. A–D: Liver biopsy from a patient who developed se

    Overwhelming hepatitis B infection with immunosuppression. Photomicrographs providing evidence that immunosuppression leads to overwhelming infection. A–D: Liver biopsy from a patient who developed severe liver failure after chemotherapy for non-Hodgkin lymphoma, which was ultimately fatal. A: Extensive hepatocyte injury and inflammation involving the portal tract and hepatic lobule. Prominent ground glass cytoplasmic inclusions representing excess HBsAg are present (100× hematoxylin-eosin). B: Severe architectural disruption with intercellular fibrosis and hepatocyte necrosis (fibrosing cholestatic hepatitis) (100× Masson trichrome stain). C: Immunohistochemical stain for HBsAg confirming the overwhelming burden of HBsAg giving diffuse cytoplasmic reactivity in virtually all cells (alkaline phosphatase stain 100×). D: Overwhelming infection is also evident with HBcAg-positive staining in virtually every nucleus and in cytoplasm as well (alkaline phosphatase stain 200×). E, F: In contrast, the same immunohistochemical stains observed above applied to the liver biopsy of a patient with chronic hepatitis B. E: Only a single cell demonstrates immunoreactivity to HBsAg (alkaline phosphatase stain 400×). F: Scattered nuclei are reactive to staining for HBcAg (alkaline phosphatase stain 200×).

  • Image Result
    An algorithm for the management of chronic hepatitis B. HBV = hepatitis B virus; HBcAg = hepatitis B core antigen; HBsAg = hepatitis B surface antigen; ER = endoplasmic reticulum; cccDNA = covalently

    An algorithm for the management of chronic hepatitis B. HBV = hepatitis B virus; HBcAg = hepatitis B core antigen; HBsAg = hepatitis B surface antigen; ER = endoplasmic reticulum; cccDNA = covalently closed circular DNA.

PII: S0002-9343(05)00477-8

doi: 10.1016/j.amjmed.2005.06.021

The American Journal of Medicine
Volume 118, Issue 12 , Pages 1413.e15-1413.e22 , December 2005